FDA Approves Mylan’s Humira Biosimilar

Hulio Version Of Adalimumab Will Have To Wait Three Years To Launch

 
• By David Wallace
  
FDA
The FDA has approved the sixth biosimilar version of Humira • Source: Shutterstock

More from Biosimilars

More from Products